This grant opportunity (PAR-24-280) from NIH supports clinical observational studies in musculoskeletal, rheumatic, and skin diseases. R01 Clinical Trials are not allowed under this funding opportunity (CFDA 93.846).
Want the full details?
Sign up free to see the agency name and the original bid posting link, plus contracting-officer contacts and AI response outlines. Every feature is free through December 31, 2026.